Oditrasertib

CAS No. 2252271-93-3

Oditrasertib( —— )

Catalog No. M36303 CAS No. 2252271-93-3

Oditrasertib (DNL-788) is a potent RIPKl inhibitor with an IC50 value of less than 100 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 211 Get Quote
5MG 330 Get Quote
10MG 534 Get Quote
25MG 1030 Get Quote
50MG 1638 Get Quote
100MG 2592 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Oditrasertib
  • Note
    Research use only, not for human use.
  • Brief Description
    Oditrasertib (DNL-788) is a potent RIPKl inhibitor with an IC50 value of less than 100 nM.
  • Description
    Oditrasertib is a receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 value lower than 100 nM. Oditrasertib can be used for the research of diseases involving inflammation or cell death.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    RIP kinase
  • Recptor
    RIP kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2252271-93-3
  • Formula Weight
    295.28
  • Molecular Formula
    C14H15F2N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N#CC1=CN=CC2=C1OCCN(C(=O)C(C)(C)C(F)F)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fidalgo JDV, et al. Preparation of substituted oxazepines and related compounds as RIPK1 inhibitors and uses thereof. WO2018213632A1. 2018-11-22.
molnova catalog
related products
  • HS-1371

    HS-1371 (HS1371) is a novel potent, ATP-competitive receptor-interacting protein kinase-3 (RIP3 or RIPK3 kinase) inhibitor with IC50 of 20.8 nM.

  • Necroptosis-IN-1

    Necroptosis-IN-1 is a potent necroptosis inhibitor of RIPK1. It is an analog of Necrostatin-1.

  • RIPK1-IN-9

    RIPK1-IN-9 is a potent and selective inhibitor of RIPK1, a dihydronaphthone compound, which inhibits U937 and L929 cells with an IC50 of 2 nM and 1.3 nM, respectively.